US equities |
SPCX $161.97 ▲+9.59% MU $909.64 ▲+1.51% TSLA $385.76 ▲+3.22% NVDA $220.18 ▲+1.71% SNDK $1,374.39 ▲+0.66% META $708.69 ▲+2.08% GOOGL $332.06 ▼-2.41% AMD $545.99 ▲+2.10%
FinancialContent

Articles published by Nano24 Ltd.

News headline image
Nano24 Reports Positive Phase 2b Results for Inhaled EXO-CD24 in Acute Respiratory Distress Syndrome (ARDS) at the CHEST Annual Meeting 2026
From Nano24 Ltd.
Via Business Wire